Irvine, CA, May 4, 2004 – In one of the largest ADHD classroom trials conducted to date, children with attention-deficit/hyperactivity disorder (ADHD) achieved ...
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...
In October 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of amphetamine mixed salts—a drug category that includes Adderall, the stimulant ...
One week after the U.S. Food and Drug Administration (FDA) announced a shortage of the immediate release formulation of amphetamine mixed salts, commonly referred to by the Adderall brand name, ...
The US Food and Drug Administration (FDA) has approved amphetamine extended-release oral suspension (Adzenys ER, Neos Therapeutics Inc) for attention-deficit ...
July 20, 2009 — Exposure to methylphenidate and amphetamine salts shows a similar risk for cardiac emergency department (ED) visits for children and adolescents ...
Barr Laboratories has issued a voluntary recall of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate (mixed salts of a single entity amphetamine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback